- Home
- KRMD vs AXR Comparison
KRMD vs AXR Comparison
Compare KRMD & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- AXR
- Stock Information
- Founded
- KRMD 1980
- AXR 1961
- Country
- KRMD United States
- AXR United States
- Employees
- KRMD N/A
- AXR N/A
- Industry
- KRMD Medical/Dental Instruments
- AXR Homebuilding
- Sector
- KRMD Health Care
- AXR Real Estate
- Exchange
- KRMD Nasdaq
- AXR Nasdaq
- Market Cap
- KRMD 134.3M
- AXR 117.0M
- IPO Year
- KRMD N/A
- AXR N/A
- Fundamental
- Price
- KRMD $4.04
- AXR $21.16
- Analyst Decision
- KRMD Strong Buy
- AXR
- Analyst Count
- KRMD 4
- AXR 0
- Target Price
- KRMD $4.63
- AXR N/A
- AVG Volume (30 Days)
- KRMD 97.1K
- AXR 8.1K
- Earning Date
- KRMD 08-06-2025
- AXR 09-12-2025
- Dividend Yield
- KRMD N/A
- AXR N/A
- EPS Growth
- KRMD N/A
- AXR 89.60
- EPS
- KRMD N/A
- AXR 2.37
- Revenue
- KRMD $36,848,451.00
- AXR $49,694,000.00
- Revenue This Year
- KRMD $21.08
- AXR $12.31
- Revenue Next Year
- KRMD $16.37
- AXR $8.40
- P/E Ratio
- KRMD N/A
- AXR $9.08
- Revenue Growth
- KRMD 19.57
- AXR N/A
- 52 Week Low
- KRMD $1.86
- AXR $17.60
- 52 Week High
- KRMD $5.05
- AXR $39.68
- Technical
- Relative Strength Index (RSI)
- KRMD 52.91
- AXR 43.95
- Support Level
- KRMD $4.01
- AXR $19.94
- Resistance Level
- KRMD $4.15
- AXR $22.35
- Average True Range (ATR)
- KRMD 0.14
- AXR 1.00
- MACD
- KRMD -0.04
- AXR -0.07
- Stochastic Oscillator
- KRMD 21.74
- AXR 39.81
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.